Reuters logo
BRIEF-Bellus Health to sell subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals
2017年3月16日 / 晚上10点28分 / 7 个月前

BRIEF-Bellus Health to sell subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals

March 16 (Reuters) - Bellus Health Inc

* Press release - Bellus Health announces the sale of subsidiary Thallion Pharmaceuticals to Taro Pharmaceuticals

* Bellus Health Inc - deal for total consideration of CA$2.7 million

* Bellus Health Inc- in addition will receive a portion of certain post-approval revenues related to shigamab program

* Bellus Health Inc - “upfront proceeds from this transaction also meaningfully extend our cash runway to Q4 2018” Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below